MoneyWorks4Me

Net sales declined -28.56%  to  Rs. 730.38 million from Rs. 1022.36 millions.The company reported a drastic decline of -95.74% in the quarter ended March 2025 to Rs. 1.51  millions from Rs. 35.46 millions  .Operating profit for the quarter ended March 2025 decreased to 103.65 millions as compared to 117.49 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 730.38 1022.36 -28.56 3182.30 3685.95 -13.66 3182.30 3685.95 -13.66
Other Income 2.10 0.48 337.50 4.98 0.98 408.16 4.98 0.98 408.16
PBIDT 103.65 117.49 -11.78 363.00 174.92 107.52 363.00 174.92 107.52
Interest 40.30 39.51 2.00 149.33 139.17 7.30 149.33 139.17 7.30
PBDT 63.35 77.98 -18.76 213.67 35.75 497.68 213.67 35.75 497.68
Depreciation 46.09 38.60 19.40 163.78 146.32 11.93 163.78 146.32 11.93
PBT 17.26 39.38 -56.17 49.89 -110.57 -145.12 49.89 -110.57 -145.12
TAX 15.75 3.92 301.79 -19.35 -20.08 -3.64 -19.35 -20.08 -3.64
Deferred Tax 15.02 2.00 651.00 -20.18 -22.00 -8.27 -20.18 -22.00 -8.27
PAT 1.51 35.46 -95.74 69.24 -90.49 -176.52 69.24 -90.49 -176.52
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 14.19 11.49 23.49 11.41 4.75 140.37 11.41 4.75 140.37
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..